Repare Therapeutics Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Repare Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Repare Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$36.4M, a 5.33% increase year-over-year.
  • Repare Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$93.7M, a 10.7% increase year-over-year.
  • Repare Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$116M, a 487% decline from 2022.
  • Repare Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$19.8M, a 81.8% increase from 2021.
  • Repare Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$109M, a 100% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$116M -$96.4M -487% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$19.8M +$88.9M +81.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$109M -$54.4M -100% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 -$54.3M -$27.9M -106% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 -$26.4M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.